Table 1.
Hormonal data and serum tumor markers at diagnosis and during follow up.
| At diagnosis of central precocious puberty | At diagnosis of granulosa cell tumor | Post surgery | |
|---|---|---|---|
| Basal LH (mU/mL) | 0.2 | 0.2 | 0.1 |
| Peak LH (mU/mL) | 6.4 | n.e. | n.e. |
| Basal FSH (mU/mL) | 2.3 | 0.1 | 0.6 |
| Peak FSH (mU/mL) | 13.4 | n.e. | n.e. |
| 18-β-estradiol (pg/mL) | 10.1 | 65 | 4.7 |
| CA125 (U/mL; n.v. 0-35) | 9.1 | 74.3 | 8.9 |
| Progesterone (ng/mL) | 0.2 | 1.7 | 0.2 |
| CEA (ng/mL; n.v. 0-5) | <0.5 | 0.5 | <0.5 |
| AFP (U/mL; n.v. 0-12) | 5.8 | 5.4 | 5.8 |
| βhCG (mU/mL; n.v. 0-5) | <2 | <2 | <2 |
LH, luteinizing hormone; FSH, follicle-stimulating hormone; CA125, Cancer Antigen-125; CEA, carcinoembryonic antigen; AFP, alpha-fetoprotein; hCG, beta human chorionic gonadotropin; n.v., normal values; n.e., not evaluated.